Journal Title：Endocrine Pathology

Endocrine Pathology publishes original articles on clinical and basic aspects of endocrine disorders. Work with animals or in vitro techniques is acceptable if it is relevant to human normal or abnormal endocrinology. Manuscripts will be considered for publication in the form of original articles, case reports, clinical case presentations, reviews, and descriptions of techniques. Submission of a paper implies that it reports unpublished work, except in abstract form, and is not being submitted simultaneously to another publication. Accepted manuscripts become the sole property of Endocrine Pathology and may not be published elsewhere without written consent from the publisher. All articles are subject to review by experienced referees. The Editors and Editorial Board judge manuscripts suitable for publication, and decisions by the Editors are final.

《內(nèi)分泌病理學》發(fā)表關(guān)于內(nèi)分泌疾病臨床和基礎(chǔ)方面的原創(chuàng)文章。如果與人類正?；虍惓?nèi)分泌學相關(guān)，則可接受動物或體外技術(shù)研究。稿件將以原創(chuàng)文章、病例報告、臨床病例陳述、評論和技術(shù)描述的形式考慮發(fā)表。提交論文意味著它報告了未發(fā)表的作品（摘要形式除外），并且不會同時提交給其他出版物。接受的稿件將成為《內(nèi)分泌病理學》的唯一財產(chǎn)，未經(jīng)出版商書面同意不得在其他地方發(fā)表。所有文章均需經(jīng)過經(jīng)驗豐富的審稿人的審查。編輯和編輯委員會判斷稿件是否適合發(fā)表，編輯的決定為最終決定。

Endocrine Pathology創(chuàng)刊于1990年，由Springer US出版商出版，收稿方向涵蓋醫(yī)學 - 病理學全領(lǐng)域，此刊是該細分領(lǐng)域中屬于非常不錯的SCI期刊，在行業(yè)細分領(lǐng)域中學術(shù)影響力較大，專業(yè)度認可很高，所以對原創(chuàng)文章要求創(chuàng)新性較高，如果您的文章質(zhì)量很高，可以嘗試。平均審稿速度 12周，或約稿 ，影響因子指數(shù)11.3，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。